Stock Events

Stock Events

Aclaris Therapeutics (8AT.F) Q2 2025 Earnings

8AT.F
May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.97
-0.65
-0.33
-0.01

Details

Expected EPS
-0.13557875708
Actual EPS
-0.10689239999999998
Surprise EPS
0.03
Surprise Percent
+21.16%

Description

⁨Aclaris Therapeutics⁩ (⁦8AT.F⁩) has reported earnings of ⁦-0.10689239999999998⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts